As Northern Vietnam transitions into a high-tech manufacturing powerhouse, the demand for high-purity Active Pharmaceutical Ingredients (APIs) and Chemical Intermediates in the Hanoi-Hai Phong economic corridor has reached an unprecedented peak.
Hanoi is no longer just a political capital; it is the nucleus of Vietnam's "Pharma 2030" vision. With the rapid expansion of industrial zones like Hoa Lac Hi-Tech Park and Quang Minh Industrial Zone, the region is attracting multi-billion dollar investments in biotechnology and pharmaceutical manufacturing. Local companies are shifting from simple drug formulation to complex synthesis, necessitating a reliable supply of high-quality intermediates.
The "China + 1" strategy has placed Hanoi in a unique position. Manufacturers in Hanoi require partners who can offer the stability of China's Factory 4.0 infrastructure while providing localized technical support. Our role as a leading supplier from Jiangxi, China, allows us to bridge this gap, ensuring that APIs and intermediates meet both WHO-GMP standards and the specific regulatory requirements of the Drug Administration of Vietnam (DAV).
Established Foundation
Global Cooperation Clients
Certified Suppliers
Annual Export Value
The future of APIs in Hanoi is defined by sustainability. Our technology roadmap focuses on three core pillars:
Jiangxi Serum Pharma Industries Co., Ltd. stands as a professional vanguard of pharmaceutical and nutritional excellence. For nearly a decade, we have dedicated our resources to the export of biological products, vaccines, Western medicines, and critically, the raw materials and intermediates that form the backbone of modern medicine.
Our experience in the Hanoi market has taught us that reliability is not just about purity; it's about the resilience of the supply chain. With our Factory 4.0 initiatives, we provide real-time tracking, rigorous QC protocols, and documented E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) that global procurement officers demand.
Request Technical Datasheet
Advanced pre-mix solutions for Hanoi pharmaceutical plants looking to optimize production efficiency and reduce cross-contamination risks.
Innovative crystal engineering to improve the solubility and shelf-life of APIs, critical for Vietnam's tropical supply chain conditions.
Utilizing state-of-the-art biological synthesis to produce high-value intermediates with lower environmental impact and higher specificity.
Apr 24, 2026
Exploring the shift toward sustainable squalene sources in the Southeast Asian cosmetic and pharma sectors.
Learn More →
Apr 17, 2026
Why this essential API remains the cornerstone of anti-inflammatory treatments in modern medicine.
Learn More →The FDA's rapid approval of oral weight-loss drugs and its impact on the global peptide synthesis market.
Learn More →All our products undergo triple testing (Raw material inspection, In-process monitoring, and Final Batch Analysis) at our ISO-certified laboratories. We provide full COA (Certificate of Analysis) and dossiers compliant with the Drug Administration of Vietnam.
Due to our strategic location in Jiangxi and robust logistics network, sea freight to Hai Phong port takes approximately 7-10 days, with express air freight reaching Hanoi in 2-3 business days.
Yes. We specialize in Pre-Mix, Co-Crystallization, and Bio-Fermentation customization to meet specific formulation requirements for Hanoi's functional food and pharmaceutical manufacturers.
We provide Drug Master Files (DMF) for major APIs and provide technical support during the registration process with Vietnamese health authorities.
Partner with a top-tier Chinese manufacturer specialized in APIs, Intermediates, and High-Purity Nutrients.
Contact Our Growth Director Today
